Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

3 structures for Q9NXR8

Entry ID Method Resolution Chain Position Source
1X4I NMR - A 362-418 PDB
7ZMX X-ray 120 A A/B 358-411 PDB
AF-Q9NXR8-F1 Predicted AlphaFoldDB

206 variants for Q9NXR8

Variant ID(s) Position Change Description Diseaes Association Provenance
VAR_021263 20 D>G HNSCC [UniProt] Yes UniProt
rs1461735101
CA369134798
3 Y>H No ClinGen
TOPMed
TCGA novel 4 L>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs4440563
CA165851904
6 D>N No ClinGen
Ensembl
CA4454064
rs775974967
7 Y>S No ClinGen
ExAC
gnomAD
CA4454066
rs764656224
9 E>D No ClinGen
ExAC
gnomAD
rs1332996963
CA369134859
10 M>K No ClinGen
gnomAD
rs780962589
CA4454099
11 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA4454102
CA4454103
rs780341286
16 M>I No ClinGen
ExAC
gnomAD
CA369134899
rs756138808
16 M>L No ClinGen
ExAC
TOPMed
gnomAD
rs756138808
CA4454101
16 M>V No ClinGen
ExAC
TOPMed
gnomAD
CA4454104
rs769040781
17 D>A No ClinGen
ExAC
gnomAD
CA4454107
rs772673743
23 T>M No ClinGen
ExAC
gnomAD
TCGA novel 25 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs201054245
CA4454108
25 M>V No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 27 E>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4454109
rs759143530
28 M>T No ClinGen
ExAC
gnomAD
CA4454110
COSM1312604
rs769127768
29 D>N Variant assessed as Somatic; 0.0 impact. urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1220186021
CA369135048
36 M>V No ClinGen
TOPMed
gnomAD
rs765499968
CA4454143
38 Q>H No ClinGen
ExAC
gnomAD
rs755044036
CA4454142
38 Q>R No ClinGen
ExAC
gnomAD
rs1408622289
CA369135084
41 Q>K No ClinGen
TOPMed
CA369135088
rs1348574955
41 Q>L No ClinGen
TOPMed
TCGA novel 42 R>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs777955673
CA4454146
43 V>L No ClinGen
ExAC
gnomAD
CA4454147
rs747570865
45 E>Q No ClinGen
ExAC
rs1213812067
CA369135140
48 M>I No ClinGen
gnomAD
CA165852168
rs867738371
51 K>R No ClinGen
Ensembl
CA4454148
rs757750682
53 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA369135184
rs1201234170
54 K>I No ClinGen
gnomAD
CA4454149
rs150115417
55 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1174278261
CA369135211
58 R>K No ClinGen
TOPMed
CA4454151
rs768225061
60 E>K No ClinGen
ExAC
gnomAD
rs747714856
CA4454153
62 M>I No ClinGen
ExAC
gnomAD
CA4454154
rs771928223
63 A>V No ClinGen
ExAC
gnomAD
CA4454155
rs772933794
65 I>T No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 68 D>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4454166
rs769542101
70 Y>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA369135624
rs1358425936
71 K>R No ClinGen
TOPMed
rs1005112662
CA165852417
78 E>D No ClinGen
gnomAD
rs867875232
CA165852418
83 A>E No ClinGen
Ensembl
rs1419837407
CA369137135
92 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA4454204
rs775492387
99 Q>E No ClinGen
ExAC
gnomAD
CA369137185
rs1388103074
99 Q>R No ClinGen
gnomAD
CA4454205
rs749343034
101 L>V No ClinGen
ExAC
TOPMed
gnomAD
rs768716282
CA4454206
103 K>E No ClinGen
ExAC
gnomAD
rs1231806217
COSM4155386
CA369137221
104 F>L kidney [Cosmic] No ClinGen
cosmic curated
gnomAD
rs1316215369
CA369137227
105 K>R No ClinGen
TOPMed
rs1311451465
CA369137233
106 M>V No ClinGen
gnomAD
rs774468293
CA4454207
109 E>D No ClinGen
ExAC
gnomAD
rs762077982
CA4454208
111 D>G No ClinGen
ExAC
gnomAD
CA165853458
rs985386218
111 D>N No ClinGen
Ensembl
CA369137304
rs1260173898
COSM1662276
113 A>S kidney [Cosmic] No ClinGen
cosmic curated
gnomAD
rs767834668
CA4454209
114 G>E No ClinGen
ExAC
gnomAD
CA4454210
rs773755720
115 I>S No ClinGen
ExAC
gnomAD
rs1268273338
CA369137328
116 T>A No ClinGen
gnomAD
CA369137356
rs1192130261
118 I>M No ClinGen
gnomAD
CA4454226
rs772493489
125 E>K No ClinGen
ExAC
rs1416724046
CA369137778
126 L>S No ClinGen
TOPMed
gnomAD
rs1193501935
CA369137784
127 D>H No ClinGen
TOPMed
TCGA novel 127 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA369137795
rs1459514654
128 T>I No ClinGen
gnomAD
rs1584993136
CA369137790
128 T>P No ClinGen
Ensembl
rs200821423
CA165853637
130 S>P No ClinGen
Ensembl
CA4454229
rs766698072
131 Q>* No ClinGen
ExAC
gnomAD
rs1418157512
CA369137846
136 H>R No ClinGen
gnomAD
CA369137854
rs1381234660
137 H>R No ClinGen
gnomAD
rs760036711
CA4454231
138 A>T No ClinGen
ExAC
gnomAD
rs1355096295
CA369137864
139 H>D No ClinGen
gnomAD
CA369137886
rs1231741074
142 T>A No ClinGen
gnomAD
rs1562976054
CA369137892
143 P>A No ClinGen
Ensembl
rs113738109
CA165853724
148 K>R No ClinGen
Ensembl
rs1280201982
CA369138009
151 P>A No ClinGen
gnomAD
TCGA novel 151 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs771218708
CA4454246
152 T>I No ClinGen
ExAC
gnomAD
CA369138039
rs1263470015
153 S>F No ClinGen
gnomAD
CA4454247
rs201298392
154 H>N No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA369138055
rs1184593183
155 H>D No ClinGen
gnomAD
rs759788131
CA4454248
155 H>R No ClinGen
ExAC
TOPMed
gnomAD
CA4454249
rs199888903
156 T>M No ClinGen
1000Genomes
ExAC
gnomAD
rs761324262
CA4454251
158 T>K No ClinGen
ExAC
TOPMed
gnomAD
CA369138084
rs1584993567
158 T>P No ClinGen
Ensembl
rs766975352
CA369138102
159 D>G No ClinGen
ExAC
gnomAD
rs766975352
CA4454252
159 D>V No ClinGen
ExAC
gnomAD
CA4454253
rs750100465
160 H>L No ClinGen
ExAC
gnomAD
TCGA novel 164 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA369138207
rs1372958359
170 A>V No ClinGen
TOPMed
rs1562976360
CA369138243
174 T>A No ClinGen
Ensembl
rs753736819
CA369138278
176 T>M No ClinGen
ExAC
gnomAD
rs753736819
CA4454256
176 T>R No ClinGen
ExAC
gnomAD
CA4454258
rs779009828
177 S>L No ClinGen
ExAC
gnomAD
rs1346268711
CA369138283
177 S>P No ClinGen
gnomAD
CA4454259
rs752617786
180 S>P No ClinGen
ExAC
gnomAD
rs3180313
CA165853725
182 E>G No ClinGen
Ensembl
rs200902834
CA165853726
184 T>S No ClinGen
Ensembl
rs1221560654
CA369138381
187 C>F No ClinGen
gnomAD
rs908317865
CA165853746
188 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA369138419
rs1458911813
193 T>P No ClinGen
gnomAD
rs772819242
CA4454273
194 A>V No ClinGen
ExAC
gnomAD
CA369138441
rs1584993728
196 S>C No ClinGen
Ensembl
CA165853748
rs938680740
198 N>D No ClinGen
TOPMed
gnomAD
rs1416234768
CA369138455
198 N>K No ClinGen
TOPMed
gnomAD
CA4454275
rs766117424
COSM744879
198 N>S lung liver [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA369138467
rs1462125454
200 Y>C No ClinGen
gnomAD
rs972793610
CA165853749
201 N>D No ClinGen
TOPMed
CA4454277
rs759383329
201 N>T No ClinGen
ExAC
gnomAD
TCGA novel 202 V>G Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1467507318
CA369138484
203 N>Y No ClinGen
gnomAD
CA369138495
rs1330215639
204 S>C No ClinGen
gnomAD
CA369138500
rs1335629427
205 S>F No ClinGen
gnomAD
TCGA novel 206 Q>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1285412842
CA369138513
207 P>H No ClinGen
gnomAD
rs201788608
CA165853751
208 L>M No ClinGen
1000Genomes
ExAC
rs201788608
CA4454279
208 L>V No ClinGen
1000Genomes
ExAC
CA369138529
rs1355725270
210 S>F No ClinGen
gnomAD
CA4454280
rs200304406
215 S>L No ClinGen
1000Genomes
ExAC
gnomAD
rs919600444
CA165853754
215 S>P No ClinGen
gnomAD
CA369138563
rs200304406
215 S>W No ClinGen
1000Genomes
ExAC
gnomAD
CA4454282
rs751727977
217 S>P No ClinGen
ExAC
gnomAD
CA369138580
rs1272214995
218 S>L No ClinGen
gnomAD
rs201712063
CA165853755
218 S>T No ClinGen
Ensembl
CA369138595
rs1259644829
221 G>C No ClinGen
gnomAD
CA4454285
rs144315352
222 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1415938665
CA369138616
225 I>L No ClinGen
TOPMed
gnomAD
CA369138650
rs1185357794
230 A>T No ClinGen
TOPMed
gnomAD
rs369051259
CA165853758
232 A>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs369051259
CA4454286
232 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4454288
rs544861013
237 A>V No ClinGen
1000Genomes
ExAC
gnomAD
rs760410824
CA165853759
238 Q>L No ClinGen
Ensembl
rs1433571423
CA369138945
COSM1084549
243 R>Q Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA4454307
rs749714240
245 T>S No ClinGen
ExAC
gnomAD
rs1211143821
CA369139042
247 S>N No ClinGen
TOPMed
CA4454309
rs779481523
255 F>C No ClinGen
ExAC
gnomAD
CA4454310
rs748565699
256 K>R No ClinGen
ExAC
gnomAD
rs776051200
CA4454312
257 N>K No ClinGen
ExAC
gnomAD
rs756187407
CA4454311
257 N>S No ClinGen
ExAC
TOPMed
gnomAD
CA4454313
rs745335917
258 N>I No ClinGen
ExAC
gnomAD
TCGA novel 259 D>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1338386869
CA369139373
261 Q>K No ClinGen
TOPMed
TCGA novel 261 Q>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA369139407
rs1584994355
262 L>F No ClinGen
Ensembl
CA165853854
rs1018252472
264 K>E No ClinGen
TOPMed
rs763727104
CA4454317
268 M>T No ClinGen
ExAC
TOPMed
gnomAD
rs762854929
CA4454316
268 M>V No ClinGen
ExAC
gnomAD
TCGA novel 270 R>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs750568317
CA4454322
274 G>A No ClinGen
ExAC
TOPMed
gnomAD
rs750568317
CA4454321
274 G>D No ClinGen
ExAC
TOPMed
gnomAD
CA165853857
rs1006647546
278 S>P No ClinGen
Ensembl
rs753997717
CA4454324
279 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA4454326
rs200011060
282 M>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA165853858
rs956892697
283 T>A No ClinGen
TOPMed
gnomAD
rs1584994382
CA369139686
284 T>A No ClinGen
Ensembl
CA4454328
rs758866749
289 A>D No ClinGen
ExAC
TOPMed
gnomAD
CA4454327
rs753080716
289 A>S No ClinGen
ExAC
gnomAD
CA4454330
rs745425792
292 S>L No ClinGen
ExAC
gnomAD
rs769371186
CA369139771
293 A>P No ClinGen
ExAC
gnomAD
rs769371186
CA4454331
293 A>T No ClinGen
ExAC
gnomAD
CA369139782
rs1246290036
294 A>P No ClinGen
TOPMed
TCGA novel 294 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 295 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs768333923
CA4454334
297 R>Q Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA4454333
rs748907453
297 R>W No ClinGen
ExAC
TOPMed
gnomAD
rs761664024
CA4454336
298 S>N No ClinGen
ExAC
TOPMed
gnomAD
rs866714436
CA165853862
300 R>Q No ClinGen
gnomAD
rs1305007588
CA369139871
302 S>N No ClinGen
TOPMed
gnomAD
CA369139881
rs1246272938
303 K>R No ClinGen
TOPMed
CA165854026
rs374432546
305 N>K No ClinGen
ESP
TOPMed
CA4454357
rs760561603
306 N>K No ClinGen
ExAC
gnomAD
rs1355077682
CA369140167
308 S>A No ClinGen
gnomAD
CA4454359
rs776728234
308 S>C No ClinGen
ExAC
gnomAD
rs1016519986
CA165854029
315 S>Y No ClinGen
TOPMed
rs1429154500
CA369140255
317 S>T No ClinGen
TOPMed
rs1434392681
CA369140269
318 S>F No ClinGen
TOPMed
gnomAD
rs1416696277
CA369140296
320 S>F No ClinGen
gnomAD
CA369140324
rs1194191883
323 S>P No ClinGen
TOPMed
gnomAD
CA369140322
rs1194191883
COSM1666235
323 S>T eye [Cosmic] No ClinGen
cosmic curated
TOPMed
gnomAD
CA4454364
rs367657969
324 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA369140342
rs1450710206
325 C>S No ClinGen
Ensembl
CA4454366
rs372931331
326 S>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA369140435
rs1484465223
333 Q>L No ClinGen
TOPMed
gnomAD
rs1484465223
CA369140433
333 Q>P No ClinGen
TOPMed
gnomAD
TCGA novel 334 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1188075254
CA369140441
334 E>K No ClinGen
gnomAD
CA4454371
rs547908706
335 I>F No ClinGen
1000Genomes
ExAC
gnomAD
CA4454370
rs547908706
335 I>V No ClinGen
1000Genomes
ExAC
gnomAD
CA4454372
rs201574570
337 Q>H No ClinGen
1000Genomes
ExAC
gnomAD
rs1396798395
CA369140503
339 T>K No ClinGen
gnomAD
CA4454374
rs747799457
342 V>M No ClinGen
ExAC
gnomAD
rs139642346
CA4454375
348 N>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1375093160
CA369140602
348 N>S No ClinGen
gnomAD
rs1290820242
CA369140654
354 T>I No ClinGen
gnomAD
TCGA novel 359 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA165854249
rs773573180
368 V>I No ClinGen
Ensembl
TCGA novel 376 C>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA369140849
rs1409021353
379 Q>H No ClinGen
gnomAD
TCGA novel 379 Q>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4454409
rs761297921
383 I>M No ClinGen
ExAC
gnomAD
rs201955164
CA4454410
390 C>W No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs762432484
CA4454412
391 V>G No ClinGen
ExAC
gnomAD
rs369549499
CA4454414
398 K>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs267601248
CA165854405
401 W>S No ClinGen
Ensembl
CA369141036
rs1562978522
404 P>A No ClinGen
Ensembl
CA4454418
rs756116032
409 A>T No ClinGen
ExAC
gnomAD
rs1584996863
CA369141107
414 G>S No ClinGen
Ensembl
rs749392825
CA4454420
415 S>G No ClinGen
ExAC
gnomAD
TCGA novel 418 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA

1 associated diseases with Q9NXR8

[MIM: 275355]: Squamous cell carcinoma of the head and neck (HNSCC)

A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes. {ECO:0000269|PubMed:12080476}. Note=The disease may be caused by variants affecting the gene represented in this entry.

Without disease ID
  • A non-melanoma skin cancer affecting the head and neck. The hallmark of cutaneous SCC is malignant transformation of normal epidermal keratinocytes. {ECO:0000269|PubMed:12080476}. Note=The disease may be caused by variants affecting the gene represented in this entry.

5 regional properties for Q9NXR8

Type Name Position InterPro Accession
domain Zinc finger, PHD-type 362 - 407 IPR001965
conserved_site Zinc finger, PHD-type, conserved site 363 - 406 IPR019786
domain Zinc finger, PHD-finger 360 - 409 IPR019787
domain Inhibitor of growth protein, N-terminal histone-binding 3 - 104 IPR024610
domain ING3, PHD domain 362 - 406 IPR042020

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

6 GO annotations of cellular component

Name Definition
NuA4 histone acetyltransferase complex A complex having histone acetylase activity on chromatin, as well as ATPase, DNA helicase and structural DNA binding activities. The complex is thought to be involved in double-strand DNA break repair. Subunits of the human complex include HTATIP/TIP60, TRRAP, RUVBL1, BUVBL2, beta-actin and BAF53/ACTL6A. In yeast, the complex has 13 subunits, including the catalytic subunit Esa1 (homologous to human Tip60).
nucleoplasm That part of the nuclear content other than the chromosomes or the nucleolus.
nucleosome A complex comprised of DNA wound around a multisubunit core and associated proteins, which forms the primary packing unit of DNA into higher order structures.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
Piccolo NuA4 histone acetyltransferase complex A heterotrimeric H4/H2A histone acetyltransferase complex with a substrate preference of chromatin over free histones. It contains a subset of the proteins found in the larger NuA4 histone acetyltransferase complex; for example, the S. cerevisiae complex contains Esa1p, Yng2p, and Epl1p.
Swr1 complex A multisubunit protein complex that is involved in chromatin remodeling. It is required for the incorporation of the histone variant H2AZ into chromatin. In S. cerevisiae, the complex contains Swr1p, a Swi2/Snf2-related ATPase, and 12 additional subunits.

2 GO annotations of molecular function

Name Definition
metal ion binding Binding to a metal ion.
methylated histone binding Binding to a histone in which a residue has been modified by methylation.

11 GO annotations of biological process

Name Definition
chromatin organization The assembly or remodeling of chromatin composed of DNA complexed with histones, other associated proteins, and sometimes RNA.
histone acetylation The modification of a histone by the addition of an acetyl group.
histone H2A acetylation The modification of histone H2A by the addition of an acetyl group.
histone H4 acetylation The modification of histone H4 by the addition of an acetyl group.
positive regulation of apoptotic process Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
positive regulation of DNA-templated transcription Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
positive regulation of double-strand break repair via homologous recombination Any process that activates or increases the frequency, rate or extent of double-strand break repair via homologous recombination.
regulation of apoptotic process Any process that modulates the occurrence or rate of cell death by apoptotic process.
regulation of cell cycle Any process that modulates the rate or extent of progression through the cell cycle.
regulation of DNA-templated transcription Any process that modulates the frequency, rate or extent of cellular DNA-templated transcription.
regulation of double-strand break repair Any process that modulates the frequency, rate or extent of double-strand break repair.

3 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q5ZK36 ING3 Inhibitor of growth protein 3 Gallus gallus (Chicken) PR
Q5HZG4 Taf3 Transcription initiation factor TFIID subunit 3 Mus musculus (Mouse) PR
Q498T3 Ing3 Inhibitor of growth protein 3 Rattus norvegicus (Rat) PR
10 20 30 40 50 60
MLYLEDYLEM IEQLPMDLRD RFTEMREMDL QVQNAMDQLE QRVSEFFMNA KKNKPEWREE
70 80 90 100 110 120
QMASIKKDYY KALEDADEKV QLANQIYDLV DRHLRKLDQE LAKFKMELEA DNAGITEILE
130 140 150 160 170 180
RRSLELDTPS QPVNNHHAHS HTPVEKRKYN PTSHHTTTDH IPEKKFKSEA LLSTLTSDAS
190 200 210 220 230 240
KENTLGCRNN NSTASSNNAY NVNSSQPLGS YNIGSLSSGT GAGAITMAAA QAVQATAQMK
250 260 270 280 290 300
EGRRTSSLKA SYEAFKNNDF QLGKEFSMAR ETVGYSSSSA LMTTLTQNAS SSAADSRSGR
310 320 330 340 350 360
KSKNNNKSSS QQSSSSSSSS SLSSCSSSST VVQEISQQTT VVPESDSNSQ VDWTYDPNEP
370 380 390 400 410
RYCICNQVSY GEMVGCDNQD CPIEWFHYGC VGLTEAPKGK WYCPQCTAAM KRRGSRHK